Guidance for the notification of serious breaches of GCP or the trial protocol

Table of Contents

Page Number(s):

A. Legal requirement

B. Purpose of the requirement

C Purpose of this guidance

D. Arrangements for notification

E. Identifying serious breaches

F. Potential actions by the MHRA

G. References

Appendix I: Notification Examples

Appendix II: Notification Form

Clinical Research News

Open Label study of entrectinib in ROS1 gene fusion-positive rare adult, paediatric and teenage/young adult cancers
Gasherbrum Bio, Inc is starting the study of GSBR-1290 drug in overweight or obese healthy adults
A new study of Dexpramipexole in adolescents and adults with severe Eosinophilic Asthma
The study of the DO-2 drug in patients with advanced or refractory solid tumours
Study to compare AT278 with standard insulin aspart NovoRapid® in participants with Type 2 Diabetes
The clinical trial of Quadruple Immunotherapy for Paediatric Patients With Relapsed or Refractory Neuroblastoma
The clinical trial evaluation of the efficacy of HIFU Treatment on Rectal Endometriosis Symptoms (ENDO-HIFU-R2)

Tulevat kliiniset tutkimukset

Clinical Research Jobs

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot